Understanding Cancer Diagnosis and Treatment During Pregnancy

This study is gathering information about pregnant women who are diagnosed with cancer. Researchers want to understand how different cancer treatments, or delays in treatment, affect both the mother's health and the health of her baby. They are looking at how children develop over time, specifically their developmental quotient (a measure of a child's development compared to others their age). You may be able to join if you are a pregnant woman diagnosed with cancer within 6 weeks before your last period or up to 6 months after your pregnancy ends. This is an observational study, meaning researchers will collect information without giving specific interventions, and they plan to include about 400 participants. The study aims to learn more about the best ways to care for mothers and babies in these situations.

Study design
This is an observational study that aims to enroll about 400 women. Researchers will collect information about their diagnosis, treatment, and outcomes.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Children's developmental quotient will be measured yearly from 3 months up to 12 years of age. Some children in this study have been followed for up to 28 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02749474

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes

UNKNOWN
Not specifiedAll AgesObservational
The Cooper Health System
~400 participants
Updated 2024-06-10 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Neonatal Developmental Quotient
Measured over Yearly from 3 months to 12 years of age
Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
1 sites across 1 states
New Jersey1
  • Elyce H Cardonick, MD · PRINCIPAL_INVESTIGATOR · Cooper Health System

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any pregnant woman diagnosed with cancer within 6 weeks before her last menstrual period or 6 months after her end of pregnancy either by delivery or miscarriage.

Exclusion

Women diagnosed with cancer more than 6 months after the end of a pregnancy.
  • Neonatal Developmental QuotientYearly from 3 months to 12 years of age

    Pediatrician asked to assess developmental age compared to chronological age, ie developmental quotient